Here's an interesting case report regarding MK in the context of...

Here's an interesting case report regarding MK in the context of autism. I haven't seen MK mentioned in that context much, and it seems a rather niche thing for now. It's probably not on Cellmid's radar at this point in time as they focus on other diseases such as cancer and fibrosis. But worth noting as research shows involvement of Midkine in an increasing number of indications.

Increased serum midkine levels in autism spectrum disorder patients
Source: International Journal of Neuroscience (http://www.tandfonline.com/doi/full/10.1080/00207454.2017.1408620?scroll=top&needAccess=true)

Maybe something to look at in the distant future.

https://www.fiercebiotech.com/speci...market-for-drug-developers-autism-drug-report